Savara (SVRA) Treasury Shares (2012 - 2026)

Savara (SVRA) reported Treasury Shares of $1454.0 for Q1 2013, little changed on a QoQ basis from $1454.0 in Q4 2012.

Savara (SVRA) has 2 years of Treasury Shares data on file, last reported at $1454.0 in Q1 2013.

  • Quarterly Treasury Shares rose 62.1% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 62.1% YoY) and the FY2025 annual result came in at $6.9 million, up 47.62% from the prior year.
  • Treasury Shares held at $1454.0 in Q1 2013 per SVRA's latest filing, from $1454.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.9 million in Q4 2025 and bottomed at $1.1 million in Q3 2022.
  • The 5-year median for Treasury Shares is $3.6 million (2024), against an average of $3.4 million.
  • The widest annual swing landed in 2022, when Treasury Shares surged 219.83%; it then gained 9.04% in 2025.
  • Tracing SVRA's Treasury Shares over 5 years: stood at $1.9 million in 2022, then jumped by 79.6% to $3.5 million in 2023, then jumped by 34.09% to $4.7 million in 2024, then soared by 47.62% to $6.9 million in 2025, then fell by 1.52% to $6.8 million in 2026.
  • Per Business Quant, the three latest SVRA Treasury Shares figures stand at $6.8 million (Q1 2026), $6.9 million (Q4 2025), and $4.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Savara 1.30 Bn 1.30 Bn - 6.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.80 Mn
Mar 31, 2026 6.80 Mn
Dec 31, 2025 6.91 Mn
Dec 31, 2025 6.91 Mn
Sep 30, 2025 4.09 Mn
Sep 30, 2025 4.09 Mn
Jun 30, 2025 4.04 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 4.20 Mn
Mar 31, 2025 4.20 Mn
Dec 31, 2024 4.68 Mn
Dec 31, 2024 4.68 Mn
Sep 30, 2024 3.75 Mn
Sep 30, 2024 3.75 Mn
Jun 30, 2024 3.56 Mn
Jun 30, 2024 3.56 Mn
Mar 31, 2024 3.63 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 3.49 Mn
Dec 31, 2023 3.49 Mn
Sep 30, 2023 2.28 Mn
Sep 30, 2023 2.28 Mn
Jun 30, 2023 2.39 Mn
Jun 30, 2023 2.39 Mn
Mar 31, 2023 2.14 Mn
Mar 31, 2023 2.14 Mn
Dec 31, 2022 1.94 Mn
Dec 31, 2022 1.94 Mn
Sep 30, 2022 1.09 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 1.14 Mn
Jun 30, 2022 1.14 Mn
Mar 31, 2022 1.27 Mn
Mar 31, 2022 1.27 Mn
Dec 31, 2021 1.27 Mn
Dec 31, 2021 1.27 Mn
Sep 30, 2021 528,334.00
Sep 30, 2021 528,334.00
Jun 30, 2021 357,022.00
Jun 30, 2021 357,022.00
Mar 31, 2021 460,709.00
Mar 31, 2021 460,709.00
Dec 31, 2020 509,397.00
Dec 31, 2020 509,397.00
Sep 30, 2020 504,647.00
Sep 30, 2020 504,647.00
Jun 30, 2020 290,125.00
Jun 30, 2020 290,125.00
Mar 31, 2020 302,875.00
Mar 31, 2020 302,875.00
Dec 31, 2019 315,625.00
Dec 31, 2019 315,625.00
Sep 30, 2019 128,375.00
Sep 30, 2019 128,375.00
Jun 30, 2019 130,000.00
Jun 30, 2019 130,000.00
Mar 31, 2019 143,125.00
Mar 31, 2019 143,125.00
Dec 31, 2018 156,250.00
Dec 31, 2018 156,250.00
Sep 30, 2018 169,375.00
Sep 30, 2018 169,375.00
Jun 30, 2018 182,500.00
Jun 30, 2018 182,500.00
Mar 31, 2018 195,625.00
Mar 31, 2018 195,625.00
Dec 31, 2017 16,190.00
Dec 31, 2017 16,190.00
Sep 30, 2017 50,000.00
Sep 30, 2017 50,000.00
Dec 31, 2016 108,411.00
Dec 31, 2016 108,411.00
Dec 31, 2015 180,813.00
Dec 31, 2015 180,813.00
Dec 31, 2013 1.45 Mn
Dec 31, 2013 1.45 Mn
Mar 31, 2013 1,454.00
Mar 31, 2013 1.45 Mn
Mar 31, 2013 1.45 Mn
Mar 31, 2013 1,454.00
Dec 31, 2012 1.45 Mn
Dec 31, 2012 1,454.00
Dec 31, 2012 1,454.00
Dec 31, 2012 1.45 Mn